Based on a commonly used model for Compound Annual Growth Rate, forecasts show that the market for needleless connectors is growing rapidly, and will continue to do so for at least the next seven years. This naturally translates to a growing need for effective connector protection. And since Conexo is a novel solution that complements other products, there is no direct competition for our intravenous line protector.
Furthermore, hospitals are losing a lot of money every year due to the consequences of poor IV line hygiene. Across the nation, nearly 1.85 billion dollars are spent annually combatting central line-associated bloodstream infections, and that, again, only represents a subset of the total infections caused by IV line contamination.